[vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]Published on April 18, 2022
Annu Navani, MD – Comprehensive Spine Sports Center
Dr. Annu Navani presents innovative intradiscal regenerative therapies for spinal pain localized to the low back or spinal discs. Dr. Navani discusses the current market for stem cell therapies and investments in regenerative medicine companies that are sponsoring various clinical trials worldwide. She describes studies focusing on mesenchymal stem cells (MSCs) and explains the need for advances in regenerative medicine for clinical applications in pain management and tissue repair. Dr. Navani also discusses the first ever head-to-head multi-center, randomized, placebo-controlled trial comparing platelet-rich plasma (PRP) or bone marrow concentrate (BMC) against a placebo for discogenic back pain, followed by the projected growth of regenerative therapies.
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]
[/vc_column_text][/vc_column][/vc_row]
Leave a Reply
You must be logged in to post a comment.